Medical News

RSS

New lung cancer pathways discovered using computer modeling

Using computer modeling, the Translational Genomics Research Institute and Scottsdale Healthcare have discovered lung cancer 'pathways' that could become targets for new drugs, according to a scientific paper published online today by the Journal of Thoracic Oncology.

7 Oct 2009

Help Group Summit 2009 on autism, learning disabilities and ADHD

The Help Group Summit 2009 - Advances and Best Practices in Autism, Learning Disabilities and ADHD took place on Friday, October 2nd and Saturday, October 3rd at The Skirball Cultural Center in Los Angeles. This cutting edge conference featured more than 20 leading experts from across the country.

7 Oct 2009

Arizona Heart Institute partners with Arizona Research Center for the advancement of cardiovascular therapies

Arizona Heart Institute, a world leading medical facility specializing in diagnosis, treatment and prevention of heart and vascular disease, and Arizona Research Center, a dedicated provider of clinical research studies, announce a partnership in the advancement of cardiovascular therapies.

7 Oct 2009

Diabetech and Cinterion Wireless Modules announce their collaboration on fourth generation GlucoMON platform

Cinterion Wireless Modules, the global leader in cellular machine-to-machine (M2M) communication modules, and Diabetech, the leader in patient-centric health care programs, today announced their collaboration on the fourth generation GlucoMON® platform, the world’s easiest-to-use wireless diabetes management system designed to help the over 220 million people worldwide struggling to manage the global diabetes and pre-diabetes pandemic.

7 Oct 2009

New report on the relationship between secondhand smoke and heart disease

The dangers of secondhand smoke have led some organizations and communities to establish smoking bans in offices, restaurants, and other public venues. The effectiveness of such bans in protecting people from health risks associated with breathing environmental tobacco smoke has been a matter of continuing debate.

7 Oct 2009

Idera Pharmaceuticals commences phase 1 IMO-2125 clinical trial for chronic HCV infection

Idera Pharmaceuticals, Inc. today announced that patient treatment has been initiated in a phase 1 clinical trial evaluating IMO-2125 in combination with ribavirin in treatment-naive patients with chronic hepatitis C virus (HCV) infection. IMO-2125 is a novel agonist of Toll-like Receptor (TLR) 9.

7 Oct 2009

Researchers validate a technique capable of quick TB diagnosis

The team headed by Doctor Manuel Casal, head of Microbiology at Reina Sofia Hospital in Cordoba has validated in patients a technique, originally produced by a German company, capable of diagnosing tuberculosis in only one day and determining whether or not it is resistant to two of the drugs used to treat this disease.

7 Oct 2009

Aryx Therapeutics to raise up to $35 million from sale of its common stock

ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that it has secured a committed equity financing facility under which it may sell up to $35 million of shares of its common stock to Commerce Court Small Cap Value Fund, Ltd. (“Commerce Court”) over a 24 month period. The maximum number of shares that can be sold by ARYx is specified in the agreement. ARYx is not obligated to utilize any of the $35 million facility and remains free to enter into and consummate other equity and debt financing transactions.

7 Oct 2009

Research study to determine association of CYP2D6 variation with tamoxifen therapy

Among women with early stage breast cancer, genetic variation of a certain enzyme appears to be associated with clinical outcomes for women treated with tamoxifen, according to a study in the October 7 issue of JAMA.

7 Oct 2009

Tranziger forms global advisory and business team to execute strategic transactions

Tranziger Limited announced today the formation of its global advisory and business team to advise and assess companies in the life sciences and healthcare sectors to execute strategic transactions and realise and optimise value from their portfolios in these turbulent times. Tranziger Limited is headquartered in London, England, UK and has offices in Washington, DC and Edinburgh.

7 Oct 2009

Roche and Genentech obtain license to use SurModics’ drug delivery system

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has signed a License and Development Agreement with Roche and Genentech, Inc., a wholly-owned member of the Roche Group.

7 Oct 2009

CBI announces agenda for upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco

The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce the full agenda for the upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco on November 19, 2009.

7 Oct 2009

Government handout of samples of potassium iodide helps to boost sales for Nukepills.com

The recent localized government handout of samples of potassium iodide has sky-rocketed sales for online merchant Nukepills.com. Recent retail orders of Iosat(TM) Potassium Iodide have increased by almost 400% and wholesale orders to vendors and medical facilities have surged as well for the authorized national distributor.

7 Oct 2009

Researchers tune Diffuse Optical Tomography for early detection of breast cancer

Clemson University researchers in collaboration with researchers at the University of Bremen, Germany, are working to make the physical pain and discomfort of mammograms a thing of the past, while allowing for diagnostic imaging eventually to be done in a home setting.

7 Oct 2009

Uterine artery embolization proves to be better than laparoscopic occlusion of uterine arteries in treating fibroids

BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – reports the publication of a study in the October 2009 issue of the Journal of Vascular Interventional Radiology in which the authors conclude that uterine artery embolization (UAE) compares favorably to laparoscopic occlusion of uterine arteries in the treatment of uterine leiomyomas (fibroids) in cases where hysterectomy or myomectomy are not options.

7 Oct 2009

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.

7 Oct 2009

Minimally invasive sling operations for stress urinary incontinence found promising

New, less invasive surgical treatments for stress urinary incontinence in women are just as effective as traditional open surgical approaches, according to Cochrane Researchers. The researchers carried out a systematic review of trials comparing different surgical approaches to treating the condition.

7 Oct 2009

Arrayit Corporation CEO updates shareholders

With the start of trading of Arrayit Corporation (ARYC) on the bulletin board in March, 2009, we initiated a deliberate and measured strategy to introduce Arrayit's scientific accomplishments of the past 13 years to our shareholders. As we have laid the foundation for the announcement of future initiatives through this awareness campaign, we have seen interest in our stock steadily increase.

7 Oct 2009

India's effort to combat poverty set back by years due to floods and droughts

Massive food shortages are now impacting hundreds of millions of Indians with floods and droughts, setting back efforts to combat poverty by years, warns World Vision.

7 Oct 2009

Aspenbio Pharma declares public offering Of 4,482,609 common stock

AspenBio Pharma, Inc. today announced that it has priced a public offering of 4,482,609 shares of its common stock at $1.70 per share.

7 Oct 2009

Medical News

New lung cancer pathways discovered using computer modeling

Help Group Summit 2009 on autism, learning disabilities and ADHD

Arizona Heart Institute partners with Arizona Research Center for the advancement of cardiovascular therapies

Diabetech and Cinterion Wireless Modules announce their collaboration on fourth generation GlucoMON platform

New report on the relationship between secondhand smoke and heart disease

Idera Pharmaceuticals commences phase 1 IMO-2125 clinical trial for chronic HCV infection

Researchers validate a technique capable of quick TB diagnosis

Aryx Therapeutics to raise up to $35 million from sale of its common stock

Research study to determine association of CYP2D6 variation with tamoxifen therapy

Tranziger forms global advisory and business team to execute strategic transactions

Roche and Genentech obtain license to use SurModics’ drug delivery system

CBI announces agenda for upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco

Government handout of samples of potassium iodide helps to boost sales for Nukepills.com

Researchers tune Diffuse Optical Tomography for early detection of breast cancer

Uterine artery embolization proves to be better than laparoscopic occlusion of uterine arteries in treating fibroids

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Minimally invasive sling operations for stress urinary incontinence found promising

Arrayit Corporation CEO updates shareholders

India's effort to combat poverty set back by years due to floods and droughts

Aspenbio Pharma declares public offering Of 4,482,609 common stock

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News